REFERENCES
- Abramson D H, Ellsworth R M, Kitchin F D, Tung G. Second non-ocular tumors in retinoblastoma survivors. Are they radiation-induced?. Ophthalmology. 1984; 91: 1351–1355
- Aerts I, Pacquement H, Doz F, Mosseri V, Desjardins L, Sastre X, Michon J, Rodriguez J, Schlienger P, Zucker J M, Quintana E. Outcome of second malignancies after retinoblastoma: A retrospective analysis of 25 patients treated at the Institut Curie. Eur J Cancer. 2004; 40: 1522–1529
- DerKinderen D J, Koten J W, Nagelkerke N JD, Tan K EWP, Beemer F A, Den Otter W. Non-ocular cancer in hereditary retinoblastoma survivors and relatives. Int J Cancer. 1988; 41: 499–504
- Desjardins L, Haye C, Schlinger P, Laurent M, Zucker J M, Bouguila H. Second non-ocular tumors in survivors of bilateral retinoblastoma. A 30-year follow-up. Ophthalmic Paedtric Genet. 1991; 12: 145–148
- De Sutter E, Messmer E, Hoepping W. Retinoblastoma: Importance of time interval in onset of second tumors. Bull Soc Belge Ophthal. 1986; 213: 27–40
- Dunkel I J, Gerald W L, Rosenfield N S, Strong E W, Abramson D H, Ghavimi F. Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: The Memorial Sloan-Kettering experience. Med Pediatr Oncol. 1998; 30: 59–62
- Eng C, Li F P, Abramson D H, Ellsworth R M, Wong F L, Goldman M B, Seddon J, Tarbell N, Boice J D, Jr. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993; 85: 1121–1128
- Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004; 96: 357–363
- Fontanesi J, Parham D M, Pratt C, Meyer D. Second malignant neoplasms in children with retinoblastoma: The St. Jude Children's Research Hospital experience. Ophthalmic Genet. 1995; 16: 105–108
- Jung T M, Terkonda R P, Haines S J, Strome S, Marentette L J. Outcome analysis of the transglabellar/subcranial approach for lesions of the anterior cranial fossa: A comparison with the classic craniotomy approach. Otolaryngol Head Neck Surg. 1997; 116: 642–646
- Kellman R M, Marentette L J. The transglabellar/subcranial approach to the anterior skull base. A review of 72 cases. Arch Otolarygol Head. 2001; 127: 687–690
- Lueder G T, Judisch F, O'Gorman T W. Second nonocular tumors in survivors of heritable retinoblastoma. Arch Ophthalmol. 1986; 104: 372–373
- Moll A C, Imhof S M, Bouter L M, Tan K EWP. Second primary tumors in patients with retinoblastoma. A review of the literature. Ophthalmic Genet. 1997; 18: 27–34
- Moore C E, Ross D A, Marentette L J. Subcranial approach to tumors of the anterior cranial base: Analysis of current and traditional surgical techniques. Otolaryngol Head Neck Surg. 1999; 121: 113–118
- Rundle P, Shields J A, Shields C L, Eagle R C, Jr, Singh A D. Sebaceous gland carcinoma of the eyelid seventeen years after irradiation for bilateral retinoblastoma. Eye. 1999; 13: 109–110
- Shields C L, Meadows A T, Shields J A, Carvalho C, Smith A F. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol. 2001; 119: 1269–1272
- Shields J A, Husson M, Shields C L, Krema H, Eagle R C, Jr, Singh A D. Orbital malignant fibrous histiocytoma following irradiation for retinoblastoma. Ophthal Plast Reconstr Surg. 2001; 17: 58–61
- Smith L M, Donaldson S S, Egbert P R, Link M P, Bagshaw M A. Aggressive management of second primary tumors in survivors of hereditary retinoblastoma. Int J Radiat Oncol. 1989; 17: 499–505